ENSPRYNG

This brand name is authorized in Canada, Ecuador, Estonia, Finland, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Poland, Romania, Turkey, United States

Active ingredients

The drug ENSPRYNG contains one active pharmaceutical ingredient (API):

1 Satralizumab
UNII YB18NF020M - SATRALIZUMAB

Satralizumab is a recombinant humanised immunoglobuline G2 (IgG2) monoclonal antibody (mAb) that binds to soluble and membrane-bound human IL-6 receptor (IL-6R) and thereby prevents IL-6 downstream signalling through these receptors.

Read about Satralizumab

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ENSPRYNG Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
ENSPRYNG Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L04AC19 L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AC Interleukin inhibitors
Discover more medicines within L04AC19

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02499681
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 189-MBE-0421
Country: EE Ravimiamet Identifier(s): 1856099
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 446332
Country: HK Department of Health Drug Office Identifier(s): 66941
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8766
Country: JP 医薬品医療機器総合機構 Identifier(s): 6399428G1024
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1092899, 1093341
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100454392
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W67936001
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699505951027
Country: US FDA, National Drug Code Identifier(s): 50242-007

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.